VG Med IF lungs bronchi traction bronchiectasis subpleural sparing volume loss lower lung fields esophagus air fluid level Fibrotic NSIP CT 59M pw Hx history of scleroderma ILD

<
<

Ashley Davidoff MD (Author)

59M pw Hx history Raynauds Syndrome
and Scleroderma 

5 Major Findings

2. Findings


Traction Bronchiectasis
Subpleural Sparing
Crowding of Airways
Displacement of Fissures
Peripheral Reticular Changes
Esophagus Air Fluid Level

Traction Bronchiectasis Definition

    • Irreversible dilation of bronchi and bronchioles
    • Occurs within areas of pulmonary fibrosis
    • Caused by surrounding fibrotic lung tissue pulling on airways

Comment

    • Often observed in the periphery of the lungs
    • Significant finding in interstitial lung diseases
    • Can be associated with increased mortality
  • Citation
    • Author: Hansell DM
    • Journal: Radiology
    • Year: 1997

Traction Bronchiectasis and Subpleural SparingNSIP Scleroderma
Subpleural Sparing Definition

    • Preservation of normal lung parenchyma beneath the pleura
    • Contrasts with surrounding abnormalities like fibrosis or consolidation

Comment

    • Can be a subtle sign on imaging
    • May indicate specific patterns of lung disease progression or resolution
  • Citation
    • Author: Remy-Jardin M
    • Journal: European Respiratory Journal
    • Year: 1994
Crowding of Airways Definition

    • A finding on imaging where the bronchi and vessels appear closer together than normal.
    • It is a direct sign of reduced lung volume (atelectasis).

Comment

    • This occurs when the lung tissue around the airways collapses or loses volume, pulling the airways together.
    • It is commonly seen in conditions such as lobar collapse, fibrosis, and bronchiectasis.
  • Citation
    • Author: Chawla A, et al.
    • Journal: Imaging in Medicine
    • Year: 2013
Displacement of Fissures Definition

    • Movement of the lines (fissures) that separate the lobes of the lung from their normal position.
    • It is considered the most reliable direct sign of lobar collapse and volume loss.

Comment

    • The fissure is pulled toward the area of volume loss.
    • The direction in which the fissure moves helps identify which lobe has collapsed.
  • Citation
    • Author: Marchiori E, et al.
    • Journal: Jornal Brasileiro de Pneumologia
    • Year: 2023
      Architectural Distortion with Inferior Fissural Displacement of left greater than right
      136592c01b01.lungs
Peripheral Reticular Changes Definition

    • A network of fine, interlacing lines (reticulations) seen on CT scans, particularly in the outer regions of the lungs.
    • These lines represent the thickening of the lung’s interstitium (the supportive tissue).

Comment

    • This is a hallmark finding of many interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis and NSIP.
    • The presence of these changes often indicates underlying lung fibrosis.
  • Citation
    • Author: Putman, R.K., et al.
    • Journal: European Respiratory Journal
    • Year: 2016

Reticular Changes Reticulation NSIP Scleroderma
Esophagus Air Fluid Level Definition

    • A visible interface between air and fluid within the esophagus on imaging
    • Typically indicative of esophageal dilation or obstruction

Comment

    • Can be seen in conditions like achalasia or esophageal strictures
    • May also be present in patients with nasogastric tubes
  • Citation
    • Author: Ott DJ
    • Journal: American Journal of Roentgenology
    • Year: 1984

Mag View Air Fluid Level in Esophagus in patient with Scleroderma and GE reflux

Related Links

Google ImagesGoogleYouTubeWikipediaRadiopediaRadiographicsPubMedChatGPTOpenEvidence

3. Diagnosis


Diagnosis Fibrotic NSIP

Topic Details
Definition
  • Nonspecific interstitial pneumonia (NSIP) is a pattern of chronic interstitial lung disease characterized by temporally homogeneous inflammation and fibrosis, distinct from usual interstitial pneumonia (UIP).
  • The fibrotic subtype of NSIP is defined by interstitial thickening predominantly due to dense collagen accumulation.
Cause
  • The exact etiology of NSIP is often unknown (idiopathic NSIP).
  • Frequently associated with underlying connective tissue diseases (CTDs), such as scleroderma, rheumatoid arthritis, or lupus.
  • Other potential contributing factors include certain viral infections (e.g., HIV), and iatrogenic causes such as drug reactions or radiation therapy.
Pathophysiology
Fibrotic Process in the Lungs resulting in architectural distortion and reticular changes

 

 

 

 

 

 

 

 

Involves epithelial injury, dysregulated repair processes, immune system activation, and abnormal fibroblast or myofibroblast function leading to excessive collagen deposition.

File:Fibroblast.jpg
SubtleGuest Wiki

  • In fibrotic NSIP, the process is dominated by interstitial fibrosis, resulting in thickened alveolar septa due to collagen accumulation.
Structural Result

Results in irreversible scarring and thickening of the lung tissue.  Thickening of the interalveolar septa

Can lead to architectural distortion, including traction bronchiectasis and volume loss, particularly in the lower lobes.
Functional Impact
  • Impairs gas exchange and lung mechanics.
  • Patients typically exhibit a restrictive pattern on pulmonary function tests (PFTs), characterized by reduced total lung capacity (TLC) and diffusion capacity for carbon monoxide (DLCO).
  • Progressive fibrosis can lead to reduced oxygen levels in the blood, diminished exercise tolerance, and respiratory failure.
Imaging
  • High-resolution computed tomography (HRCT) is the gold standard for imaging diagnosis.
  • Findings suggestive of fibrotic NSIP include
    • reticular opacities,
    • traction bronchiectasis, and
    • volume loss, often with a basal or subpleural predominance.
    • patchy ground-glass opacities are prresent but a smaller component
  • Honeycombing, common in UIP, is typically absent or minimal in NSIP.
Laboratory Findings
  • Laboratory findings in NSIP are often nonspecific.
  • Bronchoalveolar lavage (BAL) may show an increased percentage of lymphocytes.
  • Autoantibodies such as antinuclear antibody (ANA) may be positive if an associated CTD is present.
Treatment
  • Management typically involves a combination of immunosuppressive and antifibrotic therapies.
  • Initial treatment often includes corticosteroids (e.g., prednisone) and/or immunosuppressive agents such as mycophenolate mofetil (MMF), azathioprine, or cyclophosphamide.
  • For progressive fibrotic disease despite standard therapies, antifibrotic agents like nintedanib or pirfenidone may be considered.
  • Pulmonary rehabilitation and oxygen therapy can be used as supportive measures.
  • In refractory cases, combination therapy, such as rituximab with MMF, may be employed.
Prognosis
  • Generally considered more favorable than for UIP, but less so than for cellular NSIP.
  • Five-year survival rates are reported between approximately 80% and 95%, with 10-year survival rates ranging from 70% to over 90%, depending on the study and patient cohort.
  • A subset of patients may experience progressive fibrosis despite treatment, contributing to significant morbidity and mortality.
  • Factors such as male gender, disease progression, relapse, and severe functional impairment at presentation can be associated with a poorer prognosis.

Related Links

Google ImagesGoogleYouTubeWikipediaRadiopediaRadiographicsPubMedChatGPTOpenEvidence

4. Medical History and Culture


The Fibrotic Pull – Fibrotic NSIP

 

 

 The Fibrotic Pull – Fibrotic NSIP

(Verse 1)
I’m fifty-nine, it’s a heavy sky,
This Scleroderma makes me sigh.
My Raynaud’s fingers, cold and blue,
This Interstitial disease is pushing through.
My breath is short, a failing pace,
A fibrotic, shrinking, awful space.
(Chorus)
Oh, I’m Fibrotic NSIP!
I’m not the “cellular” GGO, you see.
I’m Volume Loss, the lung is tight,
My Traction Bronchiectasis is a dreadful sight!
But look! I SPARE the Subpleural space,
That’s the key to the Diagnosis!
(Verse 2)
The CT shows the lower lobes are scarred,
The bronchovascular bundles are crowded and hard.
The fissures are displaced and pulled,
By fibrosis, I am ruled!
The GGO is minimal, it’s not the main event,
(And my esophagus is full… from reflux it’s been sent).
(Chorus)
Oh, I’m Fibrotic NSIP!
I’m not the “cellular” GGO, you see.
I’m Volume Loss, the lung is tight,
My Traction Bronchiectasis is a dreadful sight!
But look! I SPARE the Subpleural space,
that’s the key to the diagnosis!
(Bridge)
That Traction is the pulling of the scar,
It yanks the airways, near and far.
The bronchiolectasis is the tiny tube,
The bronchiectasis is the bigger tube.
Both pulled and widened by the fibrosis deep,
A rigid, ugly, awful heap.
(Chorus)
Oh, I’m Fibrotic NSIP!
I’m not the “cellular” GGO, you see.
I’m Volume Loss, the lung is tight,
My Traction Bronchiectasis is a dreadful sight!
But look! I SPARE the Subpleural space,
That’s the key to the Diagnosis!

✒️ 2. The Poem

Title: “The Fibrotic Pull”
At fifty-nine, the Raynaud’s cold,
The Scleroderma takes its hold.
The breath grows short, a failing pace.
This is the Fibrotic NSIP,
Not the “cellular” GGO, light and deep.
This is the scar, the permanent stain.
The lower lobes begin to shrink,
The bronchovascular bundles link
And crowd together, pulled inside,
(The fissures show the volume loss tide).
The fibrosis pulls with all its might,
Creating Traction Bronchiectasis’ sight.
The airways, rigid, stretched, and wide.
But at the edge, the pleura’s spared,
The subpleural zone is left unpaired.
A classic sign, for all to see,
Of fibrotic NSIP.

 

Memory Images 

Traction Bronchiectasis
The Tug of War in the Jungle

Traction Bronchiectasis: A Tug-of-War of Fibrosis
Modified AI image by Ashley Davidoff Art, TheCommonVein.com (140536.MAD-04.lungs-bronchi-traction-bronchiectasis)

Muscle Man Traction

Mnemonic: Cicatrization Atelectasis and Traction Bronchiectasis Ashley Davidoff Art, AI-assisted — Memory Image – TheCommonVein.com (136598c04.MAD.01)

 

3. 📜 History, Etymology & Descriptors

 

Title (with Wiki link) Comments
History

• René Laennec (1819) first described the sound of ILD (fibrosis) with his stethoscope, calling it “dry crackles” (rales).

• Averill Liebow (1960s) revolutionized the field by creating the first major classification system (UIP, NSIP, DIP, LIP, etc.), turning ILD from one “wastebasket” term into an organized group of distinct diseases.

• High-Resolution CT in the 1980s-90s became essential for diagnosis, allowing visualization of patterns (like reticulation, GGO, honeycombing) that predict the specific type of ILD.
Etymology

• Interstitial: From Latin inter (“between”) + sistere (“to stand”).

• It describes the tissue that “stands between” the functional parts of the lung (the alveoli and the blood vessels).

• Disease: From Old French desaise, meaning “dis-ease” or “lack of comfort.”
Key Descriptors

• Umbrella Term: The single most important concept; ILD is a large group of over 200 diseases (e.g., IPF, NSIP, Sarcoidosis, HP, Asbestosis).

• Restrictive Impairment: The key physiologic finding (checked with PFTs). The lungs are stiff and cannot expand.

• Diagnostic Challenge: The cause is often unknown, requiring a “multidisciplinary” approach.

• CT is Essential: HRCT is the cornerstone of diagnosis, identifying key patterns (Reticulation, GGO, Volume Loss, Traction Bronchiectasis, Honeycombing).

• Pathology Sometimes Needed: When CT patterns are ambiguous (NSIP vs. UIP), a surgical lung biopsy is often required.

• Common Associations: Collagen Vascular Disease (e.g., Scleroderma, Rheumatoid Arthritis).

 

4. 🏛️ Cultural Context

 

Title (with Wiki link) Comments
Umbrella

• The literal metaphor. ILD is the “umbrella.”

• The diseases it covers are the “people” underneath: IPF, NSIP, Sarcoidosis, HP, Asbestosis, Scleroderma-ILD, etc.
Construction (Mortar)

• The Bricks are the alveoli (air sacs).

• The Mortar is the interstitium (the “space between”).

• In ILD, the bricks are fine, but the mortar gets inflamed, thick, and hard (fibrosis). This makes the entire wall (the lung) stiff, heavy, and non-functional.
Clothing (Corset)

• A perfect metaphor for “Restrictive” physiology.

 

• The lungs (the person) are healthy and want to expand.

• The fibrosis (the corset) is squeezing the lungs, physically restricting their ability to take a deep breath.
Food (Texture)

• A healthy lung is a light, airy Sponge cake or Meringue.

• A fibrotic ILD lung is a dense, hard, Biscotti or Hardtack. All the air and flexibility are gone.

 

5. 👥 Notable People

 

Category Names & Comments
Contributors

• Averill Abraham Liebow: (1911-1978) American pathologist. He is the “father” of the modern classification of interstitial pneumonias (UIP, NSIP, DIP, LIP). His work is the foundation for our entire understanding of ILD.

• René Laennec: (1781-1826) First to clinically describe the “dry crackles” (rales) heard with the stethoscope, which are the hallmark sound of the fibrosis in many ILDs.
Patients

• (This is an umbrella term. This lists patients with specific ILDs, like Idiopathic Pulmonary Fibrosis (IPF).)

• Marlon Brando: (1924-2004) American actor. He died of respiratory failure from pulmonary fibrosis (IPF).

• Evel Knievel: (1938-2007) American stunt performer. He died of pulmonary fibrosis (IPF).

• Peter Benchley: (1940-2006) American author, best known for Jaws. He died from pulmonary fibrosis.

• Bob Gibson: (1935-2020) Hall of Fame baseball pitcher. He suffered from pulmonary fibrosis.

 

Related Links

Google ImagesGoogleYouTubeWikipediaRadiopediaRadiographicsPubMedChatGPTOpenEvidence

6. MCQs


Part A

Question Answer
1. Basic Science: What is the fundamental pathomechanical process that causes traction bronchiectasis? A. Chronic airway infection leading to bronchial wall destruction and mucus plugging.
B. Congenital weakness in the bronchial cartilage leading to airway collapse and subsequent dilation.
C. Outward pulling forces from surrounding parenchymal fibrosis that distort and irreversibly dilate the airways.
D. Infiltration of the bronchial walls by inflammatory cells, causing direct weakening and widening.
2. Basic Science: The development of fibrosis, which is the underlying cause of traction bronchiectasis, is primarily driven by the activation of fibroblasts into myofibroblasts. Which cytokine is the most potent and direct mediator of this transformation? A. Interleukin-1 (IL-1)
B. Tumor Necrosis Factor-alpha (TNF-α)
C. Interferon-gamma (IFN-γ)
D. Transforming Growth Factor-beta (TGF-β)
3. Clinical: The presence and extent of traction bronchiectasis on HRCT in a patient with a known fibrotic interstitial lung disease (like fNSIP or IPF) is a significant prognostic indicator. It is most strongly associated with: A. A favorable response to immunosuppressive therapy.
B. A higher likelihood of spontaneous disease remission.
C. Increased severity of fibrosis and higher mortality.
D. A lower risk of developing pulmonary hypertension.
4. Clinical: While traction bronchiectasis is a hallmark of fibrotic lung disease, in which of the following conditions is it LEAST likely to be a dominant feature? A. Usual Interstitial Pneumonia (UIP)
B. Cellular Nonspecific Interstitial Pneumonia (cNSIP)
<input_type=”checkbox”> C. Chronic Hypersensitivity Pneumonitis (cHP)
<input_type=”checkbox”> D. End-stage Sarcoidosis
5. Imaging: In differentiating fNSIP from UIP, the pattern of traction bronchiectasis can be a clue. Which description best fits the typical appearance of traction bronchiectasis in fNSIP? A. Primarily associated with extensive honeycombing in a basal and subpleural distribution.
B. Uniformly cylindrical, involving only the central cartilaginous airways.
C. Associated with ground-glass opacities and reticulation, often with relative subpleural sparing.
D. Almost exclusively seen in the upper lobes with associated large bullae.
6. Imaging: Besides fNSIP and UIP, traction bronchiectasis is a key feature in other fibrotic lung diseases. In which of the following diseases is it classically associated with a mid- or upper-lung zone predominance and possibly centrilobular nodules? A. Asbestosis
B. Rheumatoid Arthritis-associated ILD (UIP pattern)
C. Chronic Hypersensitivity Pneumonitis (cHP)
D. Drug-induced lung injury (Amiodarone)
7. Imaging: On HRCT, how is traction bronchiectasis definitively differentiated from other forms of bronchiectasis, such as post-infectious bronchiectasis? A. Traction bronchiectasis always shows a “signet ring” sign, while post-infectious does not.
B. Traction bronchiectasis occurs within and is caused by surrounding parenchymal fibrosis, whereas post-infectious bronchiectasis is a primary airway disease that may or may not have adjacent fibrosis.
C. Post-infectious bronchiectasis is always reversible, while traction bronchiectasis is permanent.
D. Traction bronchiectasis exclusively affects the lower lobes, whereas post-infectious bronchiectasis affects the upper lobes.

Part B

1. What is the fundamental pathomechanical process that causes traction bronchiectasis?
A. Chronic airway infection leading to bronchial wall destruction and mucus plugging. ❌
  • Incorrect. This describes the “vicious cycle” hypothesis for other forms of bronchiectasis, such as post-infectious or cystic fibrosis-related, not traction bronchiectasis.
B. Congenital weakness in the bronchial cartilage leading to airway collapse and subsequent dilation. ❌
  • Incorrect. This describes the mechanism for conditions like Williams-Campbell syndrome, which is a rare congenital cause of bronchiectasis, not traction bronchiectasis.
C. Outward pulling forces from surrounding parenchymal fibrosis that distort and irreversibly dilate the airways. ✅
  • Correct. Traction bronchiectasis is, by definition, the result of mechanical pulling (traction) from scarred and fibrotic lung tissue surrounding the bronchi, causing them to widen irreversibly.
  • Westcott JL, Cole SR. Radiology. 1986
D. Infiltration of the bronchial walls by inflammatory cells, causing direct weakening and widening. ❌
  • Incorrect. While inflammation is part of the overall disease process in ILDs, the specific mechanism of traction bronchiectasis is the mechanical pulling by established fibrosis, not direct inflammation of the airway wall itself.
2. The development of fibrosis, which is the underlying cause of traction bronchiectasis, is primarily driven by the activation of fibroblasts into myofibroblasts. Which cytokine is the most potent and direct mediator of this transformation?
A. Interleukin-1 (IL-1) ❌
  • Incorrect. IL-1 is a pro-inflammatory cytokine but is not considered the principal direct driver of fibroblast-to-myofibroblast transformation.
B. Tumor Necrosis Factor-alpha (TNF-α) ❌
  • Incorrect. Like IL-1, TNF-α is a key inflammatory mediator but is not the primary profibrotic cytokine responsible for myofibroblast activation.
C. Interferon-gamma (IFN-γ) ❌
  • Incorrect. IFN-γ is generally considered to have anti-fibrotic properties, acting to inhibit collagen synthesis.
D. Transforming Growth Factor-beta (TGF-β) ✅
  • Correct. TGF-β is the most well-established and potent cytokine that promotes fibrosis by inducing the differentiation of fibroblasts into collagen-producing myofibroblasts, leading to the scar tissue that causes traction bronchiectasis.
  • Khalil N, et al. Am J Respir Cell Mol Biol. 2020
3. The presence and extent of traction bronchiectasis on HRCT in a patient with a known fibrotic interstitial lung disease (like fNSIP or IPF) is a significant prognostic indicator. It is most strongly associated with:
A. A favorable response to immunosuppressive therapy. ❌
  • Incorrect. Traction bronchiectasis indicates irreversible fibrosis, which is generally less responsive to therapy than active inflammation (often seen as ground-glass opacity).
B. A higher likelihood of spontaneous disease remission. ❌
  • Incorrect. Traction bronchiectasis is a sign of established, often progressive fibrosis, not a disease process likely to remit spontaneously.
C. Increased severity of fibrosis and higher mortality. ✅
  • Correct. Multiple studies have shown that the presence and severity of traction bronchiectasis are powerful radiologic markers that correlate with the severity of fibrosis, progressive decline in lung function, and increased mortality across different types of fibrotic ILD.
  • Hida T, et al. Eur J Radiol Open. 2021
D. A lower risk of developing pulmonary hypertension. ❌
  • Incorrect. Severe fibrosis, of which traction bronchiectasis is a sign, often leads to destruction of the pulmonary vascular bed, which can cause or worsen pulmonary hypertension (Group 3 PH), thus indicating a higher, not lower, risk.
4. While traction bronchiectasis is a hallmark of fibrotic lung disease, in which of the following conditions is it LEAST likely to be a dominant feature?
A. Usual Interstitial Pneumonia (UIP) ❌
  • Incorrect. Traction bronchiectasis is a key and required feature for a definite UIP pattern on HRCT.
B. Cellular Nonspecific Interstitial Pneumonia (cNSIP) ✅
  • Correct. The cellular subtype of NSIP is defined pathologically by interstitial inflammation with minimal to no fibrosis. Therefore, traction bronchiectasis, which is caused by fibrosis, is characteristically absent or minimal.
  • Travis WD, et al. Am J Respir Crit Care Med. 2002
C. Chronic Hypersensitivity Pneumonitis (cHP) ❌
  • Incorrect. The fibrotic form of chronic HP is characterized by fibrosis and architectural distortion, which includes traction bronchiectasis.
D. End-stage Sarcoidosis ❌
  • Incorrect. As sarcoidosis progresses to its fibrotic, end-stage form, it causes significant parenchymal scarring and architectural distortion, which commonly results in traction bronchiectasis, often with an upper-lobe predominance.
5. In differentiating fNSIP from UIP, the pattern of traction bronchiectasis can be a clue. Which description best fits the typical appearance of traction bronchiectasis in fNSIP?
A. Primarily associated with extensive honeycombing in a basal and subpleural distribution. ❌
  • Incorrect. This description is the hallmark of a definite UIP pattern. Honeycombing is characteristically absent or minimal in NSIP.
B. Uniformly cylindrical, involving only the central cartilaginous airways. ❌
  • Incorrect. Traction bronchiectasis typically affects peripheral airways within areas of fibrosis and is irregular, not uniform or limited to central airways.
C. Associated with ground-glass opacities and reticulation, often with relative subpleural sparing. ✅
  • Correct. The typical fibrotic NSIP pattern consists of ground-glass opacities and fine reticulation with associated traction bronchiectasis. A key distinguishing feature from UIP is the relative sparing of the immediate subpleural lung.
  • Silva CI, et al. Radiographics. 2008
D. Almost exclusively seen in the upper lobes with associated large bullae. ❌
  • Incorrect. This describes a pattern more consistent with advanced smoking-related lung disease or fibrotic sarcoidosis, not the typical basal predominance of fNSIP.
6. Besides fNSIP and UIP, traction bronchiectasis is a key feature in other fibrotic lung diseases. In which of the following diseases is it classically associated with a mid- or upper-lung zone predominance and possibly centrilobular nodules?
A. Asbestosis ❌
  • Incorrect. Asbestosis typically causes a basilar and subpleural predominant fibrosis, similar in distribution to UIP.
B. Rheumatoid Arthritis-associated ILD (UIP pattern) ❌
  • Incorrect. When RA-ILD presents with a UIP pattern, it has the same basal and peripheral predominance as idiopathic UIP.
C. Chronic Hypersensitivity Pneumonitis (cHP) ✅
  • Correct. Chronic HP often presents with fibrosis (including traction bronchiectasis) in a mid- or upper-lung zone distribution. The presence of poorly defined centrilobular nodules and air trapping (mosaic attenuation) are also key features that suggest cHP.
  • Silva CIS, et al. RadioGraphics. 2007
D. Drug-induced lung injury (Amiodarone) ❌
  • Incorrect. While amiodarone can cause fibrotic lung disease, its classic presentation often involves high-attenuation opacities due to the iodine content of the drug, and the distribution is not classically mid- to upper-zonal.
7. On HRCT, how is traction bronchiectasis definitively differentiated from other forms of bronchiectasis, such as post-infectious bronchiectasis?
A. Traction bronchiectasis always shows a “signet ring” sign, while post-infectious does not. ❌
  • Incorrect. The “signet ring” sign (bronchus diameter greater than the adjacent pulmonary artery) can be seen in various types of bronchiectasis, not just traction type.
B. Traction bronchiectasis occurs within and is caused by surrounding parenchymal fibrosis, whereas post-infectious bronchiectasis is a primary airway disease that may or may not have adjacent fibrosis. ✅
  • Correct. This is the core distinction. The key diagnostic feature of traction bronchiectasis is that the dilated airways are situated within an area of clear parenchymal pathology (fibrosis, reticulation, architectural distortion). Other forms of bronchiectasis are primary airway pathologies.
  • Hansell DM, et al. Radiology. 2008
C. Post-infectious bronchiectasis is always reversible, while traction bronchiectasis is permanent. ❌
  • Incorrect. Both conditions represent permanent, irreversible airway dilation. While some *pseudo*bronchiectasis after acute inflammation can be reversible, established bronchiectasis of any primary cause is not.
D. Traction bronchiectasis exclusively affects the lower lobes, whereas post-infectious bronchiectasis affects the upper lobes. ❌
  • Incorrect. The distribution of traction bronchiectasis depends entirely on the location of the underlying fibrosis (e.g., basal in UIP/NSIP, upper lobes in sarcoidosis). Post-infectious bronchiectasis can also occur in any lobe.

Related Links

Google ImagesGoogleYouTubeWikipediaRadiopediaRadiographicsPubMedChatGPTOpenEvidence

7. Memory Page


 

I = N Bronchovascular Distribution
I = No Honeycombing 
White Straight Arrow = Subpleural Sparing
White Curved Arrow = GGO


Tug of War in the Jungle

Artistic Rendering of Traction Bronchiectasis
Modified AI image by Ashley Davidoff MD, TheCommonVein.com (140536.MAD. lungs-bronchi-traction-bronchiectasis)

Traction Bronchiectasis: A Tug-of-War of Fibrosis

This AI-assisted memory image is a metaphorical collage illustrating the mechanism of Traction Bronchiectasis, a common finding in advanced interstitial lung disease. The image uses a tug-of-war theme where men pull thick ropes on a tracheobronchial “tree,” symbolizing the external traction exerted by dense scar tissue (fibrosis). The central CT image shows the result: permanently dilated bronchi mimicking the stretched rope segments, with the jungle background representing the disordered and scarred interstitial architecture of fibrotic NSIP (Nonspecific Interstitial Pneumonia).The metaphor vividly explains that traction bronchiectasis is caused by the stiffening and contraction of the surrounding lung tissue, which mechanically pulls the bronchial walls open, differentiating it from forms caused by muscle wall destruction or obstruction.
Modified AI image by Ashley Davidoff Art, TheCommonVein.com (140536.MAD-04.lungs-bronchi-traction-bronchiectasis)

The Fibrotic Tug on the Tree

The lung’s soft landscape, once green and free,
Is now a jungle, a tangled, dense tree.
The NSIP whispers, a fibrous slow hand,
Stiffening pliable tissue and distorted  large bands .

See the CT’s small windows, a central clear view,
Where the airways are widened, pathologically new.
They stretch and they gape, they cannot retract,
For the pull of the scar tissue holds them fast, exact.

Like men in the collage, with ropes thick and taut,
The collagen fibers the bronchi have caught.
They pull with a force, a silent, slow fight,
Exerting their traction with desperate might.

The tracheobronchial tree, once a conduit of air,
Is locked in a struggle, a permanent snare.
This widening, lasting, this structural breach,
Is Traction Bronchiectasis, a lesson they teach.
The jungle of fibrosis has won its grim prize,
Reflected in tubes with unblinking eyes.

 

Related Links

Google ImagesGoogleYouTubeWikipediaRadiopediaRadiographicsPubMedChatGPTOpenEvidence
>
>

1. Challenge

2. Findings

3. Diagnosis

4. Medical History and Culture

6. MCQs

7. Memory Page